Nicorama Mint: Uses, Dosage & Side Effects

A mint-flavored nicotine replacement therapy medicated chewing gum designed to help adults quit smoking by reducing nicotine withdrawal symptoms and cravings

Rx ATC: N07BA01 NRT
Active Ingredient
Nicotine (as polacrilex)
Available Forms
Medicated chewing gum
Strengths
2 mg, 4 mg
Known Brands
Nicorama Mint

Nicorama Mint is a nicotine replacement therapy (NRT) product in the form of a mint-flavored medicated chewing gum containing nicotine. It is designed to help adults who are dependent on tobacco to quit smoking by providing a controlled, lower dose of nicotine through the oral mucosa, thereby reducing the severity of withdrawal symptoms and cravings that commonly occur during smoking cessation. Nicorama Mint is available in 2 mg and 4 mg strengths and is used as part of a comprehensive quit-smoking program. Clinical evidence from Cochrane systematic reviews consistently demonstrates that NRT, including nicotine gum, significantly increases the chances of successfully quitting smoking compared with placebo or no treatment.

Quick Facts: Nicorama Mint

Active Ingredient
Nicotine
Drug Class
NRT
ATC Code
N07BA01
Common Uses
Smoking Cessation
Available Forms
Chewing Gum
Prescription Status
Rx

Key Takeaways

  • Nicorama Mint is a nicotine replacement therapy medicated chewing gum that helps smokers quit by delivering controlled doses of nicotine through the oral mucosa, reducing withdrawal symptoms and cravings.
  • Available in 2 mg (for smokers with lower dependence) and 4 mg (for smokers who have their first cigarette within 30 minutes of waking), allowing the treatment to be tailored to individual nicotine dependence levels.
  • The correct “chew and park” technique is essential for proper nicotine absorption – chew slowly until a tingling taste appears, then park the gum between cheek and gum for about one minute before repeating.
  • Cochrane systematic reviews demonstrate that nicotine gum increases the rate of successful smoking cessation by approximately 50–60% compared with placebo, with even higher success rates when combined with behavioral support.
  • Treatment typically lasts 8–12 weeks with gradual dose reduction, and the most common side effects (mouth irritation, hiccups, jaw ache) are generally mild and decrease with proper technique and continued use.

What Is Nicorama Mint and What Is It Used For?

Quick Answer: Nicorama Mint is a mint-flavored nicotine medicated chewing gum used as nicotine replacement therapy (NRT) to help adults stop smoking. It delivers nicotine through the lining of the mouth to reduce cravings and withdrawal symptoms during smoking cessation.

Nicorama Mint belongs to the class of medications known as nicotine replacement therapies (NRT). It contains nicotine, the same substance that creates physical dependence in tobacco users, but delivers it in a controlled, pharmaceutical form through the oral mucosa (the lining of the mouth) rather than through the lungs via tobacco smoke. By providing a measured dose of nicotine without the thousands of harmful chemicals found in tobacco smoke – including tar, carbon monoxide, formaldehyde, benzene, and dozens of known carcinogens – Nicorama Mint allows smokers to gradually wean themselves off their nicotine dependence while avoiding the most dangerous aspects of continued tobacco use.

Tobacco smoking remains one of the leading preventable causes of death worldwide. According to the World Health Organization (WHO), tobacco kills more than 8 million people each year, including approximately 1.3 million non-smokers who are exposed to secondhand smoke. Nicotine, while being the primary addictive substance in tobacco, is not the principal cause of smoking-related diseases. Rather, it is the combustion products of tobacco – the tars, particulate matter, and toxic gases – that are responsible for the overwhelming majority of smoking-related cancers, cardiovascular diseases, and chronic respiratory conditions. This fundamental pharmacological distinction forms the scientific basis for nicotine replacement therapy.

The nicotine in Nicorama Mint is bound to an ion-exchange resin (polacrilex), which allows for controlled, gradual release of nicotine when the gum is chewed. As the user chews the gum, nicotine is released from the resin complex and absorbed through the buccal and sublingual mucosa – the tissues lining the cheeks, gums, and the underside of the tongue. This oromucosal absorption pathway delivers nicotine to the bloodstream more slowly than smoking but significantly faster than gastrointestinal absorption, providing a pharmacokinetic profile that partially replicates the satisfaction of smoking while avoiding the harmful effects of inhaled tobacco smoke.

The mint flavoring in Nicorama Mint serves both a practical and therapeutic purpose. It helps mask the naturally bitter taste of nicotine, improving palatability and user compliance. Pleasant flavor is a well-documented factor in adherence to NRT regimens, and mint remains one of the most popular and well-tolerated flavor options. Additionally, the fresh mint sensation can provide a sensory alternative to smoking, helping to address the oral fixation component of tobacco dependence.

Nicorama Mint is indicated for the relief of nicotine withdrawal symptoms and cravings associated with smoking cessation. It can be used in two main approaches:

  • Abrupt cessation (fixed quit date): The smoker sets a specific quit date, stops smoking completely on that date, and uses Nicorama Mint to manage withdrawal symptoms and cravings. This is the most commonly recommended approach and is supported by the strongest clinical evidence.
  • Gradual reduction (cut down to quit): The smoker reduces the number of cigarettes smoked per day while using Nicorama Mint to manage cravings between cigarettes, with the goal of eventually stopping smoking entirely. This approach may be suitable for smokers who are not ready or able to quit abruptly, though the evidence base for this method is smaller.

The clinical evidence supporting nicotine gum for smoking cessation is extensive and robust. A landmark Cochrane systematic review, encompassing more than 130 randomized controlled trials and tens of thousands of participants, found that NRT in any form increases the rate of successful long-term smoking cessation by approximately 50–60% compared with placebo or no pharmacological intervention. The relative risk of quitting with nicotine gum specifically was found to be approximately 1.49 (95% confidence interval 1.40–1.60), meaning that for every 100 smokers who would have quit without help, approximately 149 would successfully quit when using nicotine gum. When combined with behavioral support or counseling, the success rates are even higher.

Why Nicotine Replacement Therapy Works

Nicotine addiction involves both physical dependence (the body’s adaptation to regular nicotine exposure) and behavioral or psychological components (the habits, rituals, and emotional associations linked to smoking). NRT addresses the physical component by providing enough nicotine to reduce withdrawal symptoms – such as irritability, difficulty concentrating, restlessness, anxiety, increased appetite, and strong cravings – while allowing the smoker to focus on breaking the behavioral and psychological aspects of their addiction.

What Should You Know Before Taking Nicorama Mint?

Quick Answer: Do not use Nicorama Mint if you are a non-smoker or if you are allergic to nicotine or any of the gum’s ingredients. Consult a healthcare provider before use if you have cardiovascular disease, uncontrolled hypertension, diabetes, peptic ulcers, or liver or kidney disease. Special caution is needed during pregnancy and breastfeeding.

Contraindications

Nicorama Mint should not be used by individuals who have never smoked or who are not currently dependent on nicotine. The product is specifically designed for tobacco users who wish to quit. It should also not be used by anyone with a known hypersensitivity (allergy) to nicotine or to any of the other ingredients in the gum, including the sweeteners, flavoring agents, or the gum base components. Children under the age of 12 should not use this product, and adolescents aged 12–17 should only use it under the supervision of a healthcare provider.

Individuals with temporomandibular joint (TMJ) disorders may find that the chewing action exacerbates their jaw pain and dysfunction. In these cases, alternative NRT formulations (such as nicotine patches, lozenges, inhalers, or nasal sprays) may be more appropriate. Similarly, individuals with significant dental problems, dentures, or oral inflammation should consult their dentist or doctor before using nicotine gum, as the chewing action and nicotine release may irritate already compromised oral tissues.

Warnings and Precautions

Before starting Nicorama Mint, discuss the following conditions with your healthcare provider:

  • Cardiovascular disease: Nicotine increases heart rate and blood pressure and can cause vasoconstriction. Patients with recent myocardial infarction (heart attack, within the past 4 weeks), unstable or worsening angina pectoris, Prinzmetal’s angina, severe cardiac arrhythmias, recent cerebrovascular accident (stroke), or uncontrolled hypertension should use NRT only under close medical supervision. However, it is important to note that the cardiovascular risks of continued smoking far exceed those of NRT.
  • Peptic ulcers and gastritis: Swallowed nicotine can stimulate gastric acid secretion and may exacerbate peptic ulcer disease, gastritis, or gastroesophageal reflux disease (GERD). Proper chewing technique (the “chew and park” method) minimizes the amount of nicotine swallowed, but patients with active gastrointestinal disease should be monitored.
  • Diabetes mellitus: Smoking cessation, with or without NRT, can alter insulin requirements. Nicotine itself can affect blood glucose levels. Patients with diabetes should monitor their blood glucose levels more frequently when initiating NRT and during the smoking cessation process, and insulin or oral antidiabetic medication doses may need adjustment.
  • Hyperthyroidism and pheochromocytoma: Nicotine stimulates catecholamine release, which can worsen symptoms of hyperthyroidism or precipitate hypertensive crises in patients with pheochromocytoma. Use with caution and under medical supervision in these conditions.
  • Hepatic and renal impairment: Nicotine is primarily metabolized in the liver and its metabolites are excreted by the kidneys. Patients with moderate to severe hepatic or renal impairment may have altered nicotine clearance, potentially leading to higher systemic nicotine levels. Dose adjustment or closer monitoring may be necessary.

Pregnancy and Breastfeeding

Smoking during pregnancy poses severe risks to both the mother and the developing fetus, including increased risk of miscarriage, premature birth, low birth weight, placental abruption, and sudden infant death syndrome (SIDS). Ideally, pregnant women should quit smoking without the use of any nicotine-containing products. Behavioral counseling and support should be the first-line approach.

If non-pharmacological methods have been unsuccessful and the woman continues to smoke, a healthcare provider may consider NRT as a less harmful alternative to continued smoking. The intermittent dosing provided by nicotine gum may be preferred over continuous-release forms (such as patches) during pregnancy, as it results in lower average daily nicotine exposure and avoids continuous fetal nicotine exposure, particularly during sleep. The decision to use NRT during pregnancy must be individualized, weighing the known risks of continued smoking against the potential risks of nicotine exposure from NRT.

Nicotine passes into breast milk. The concentration of nicotine in breast milk is approximately 2.9 times higher than the corresponding maternal plasma concentration. Breastfeeding women should ideally quit smoking without NRT. If NRT is used during breastfeeding, nicotine gum may be preferred over patches because the intermittent dosing allows timing of breastfeeding to coincide with the lowest nicotine levels (typically before the next piece of gum). The health benefits of breastfeeding generally outweigh the risks of nicotine exposure from NRT, and NRT is considered preferable to continued smoking during breastfeeding.

Driving and Operating Machinery

Nicorama Mint is not expected to impair the ability to drive or operate machinery. However, it is important to note that smoking cessation itself can temporarily affect concentration, mood, and cognitive function due to nicotine withdrawal. Individuals should be aware of these potential effects during the early stages of their quit attempt and exercise appropriate caution.

How Does Nicorama Mint Interact with Other Drugs?

Quick Answer: Nicotine itself has relatively few direct drug interactions. However, smoking cessation (with or without NRT) can significantly alter the metabolism of many medications because tobacco smoke induces certain liver enzymes. When a person stops smoking, the blood levels of affected drugs may increase, potentially requiring dose adjustments.

Understanding drug interactions with Nicorama Mint requires distinguishing between the effects of nicotine itself and the effects of smoking cessation. While nicotine has limited direct pharmacokinetic interactions with most medications, tobacco smoke contains polycyclic aromatic hydrocarbons (PAHs) that are potent inducers of cytochrome P450 (CYP) enzymes, particularly CYP1A2 and to a lesser extent CYP2B6. When a person stops smoking, these enzyme induction effects gradually diminish over 1–2 weeks, potentially leading to increased blood levels of drugs metabolized by these pathways. This phenomenon is clinically important and may necessitate dose adjustments for several commonly prescribed medications.

The following table summarizes clinically significant interactions that healthcare providers and patients should be aware of during smoking cessation with Nicorama Mint:

Clinically Significant Drug Interactions During Smoking Cessation
Drug Interaction Type Clinical Effect Action Required
Theophylline CYP1A2 substrate Blood levels may increase by up to 100% after cessation, risking toxicity Monitor levels closely; reduce dose by up to 50%
Clozapine CYP1A2 substrate Plasma levels may increase significantly, increasing side effect risk Monitor levels; reduce dose as needed under psychiatrist guidance
Olanzapine CYP1A2 substrate Moderate increase in plasma levels possible Monitor for increased sedation or side effects
Warfarin CYP1A2 substrate (R-warfarin) INR may increase after cessation due to reduced warfarin clearance Monitor INR frequently; adjust dose as necessary
Insulin Nicotine effect on insulin sensitivity Smoking cessation may increase insulin sensitivity, reducing insulin requirements Monitor blood glucose; consider insulin dose reduction
Beta-blockers (propranolol) CYP1A2 substrate Blood levels may increase after cessation Monitor blood pressure and heart rate; adjust dose if needed
Caffeine CYP1A2 substrate Caffeine levels may increase by up to 250% after cessation Consider reducing caffeine intake to avoid jitteriness and insomnia

Important Considerations Regarding Food and Beverages

The absorption of nicotine from Nicorama Mint through the oral mucosa is pH-dependent. Acidic beverages – including coffee, carbonated drinks, fruit juices, and alcohol – can lower the pH of the mouth, significantly reducing nicotine absorption and making the gum less effective. For optimal results, avoid eating or drinking anything (other than water) for at least 15 minutes before and during the use of each piece of gum. This is a commonly overlooked factor that can contribute to perceived NRT treatment failure.

Simultaneous use of Nicorama Mint with other nicotine-containing products (patches, lozenges, inhalers, nasal sprays, or e-cigarettes) should only be undertaken under healthcare provider supervision. Combination NRT therapy – typically a background nicotine patch combined with as-needed nicotine gum or lozenges – has been shown in clinical trials to be more effective than single-product NRT and is recommended in several treatment guidelines for heavily dependent smokers. However, this combination approach should be monitored to avoid excessive nicotine intake.

What Is the Correct Dosage of Nicorama Mint?

Quick Answer: Use the 2 mg strength if you smoke your first cigarette more than 30 minutes after waking, or the 4 mg strength if you smoke within 30 minutes of waking. Use 8–12 pieces per day initially, with a maximum of 15 pieces in 24 hours. Gradually reduce the number of pieces over 8–12 weeks.

The correct dosage of Nicorama Mint depends on your level of nicotine dependence, which is most reliably assessed using the time to first cigarette after waking – a validated proxy measure from the Fagerström Test for Nicotine Dependence (FTND). This simple metric has been shown to correlate well with daily nicotine intake and is the primary criterion for selecting the appropriate gum strength.

Adults (18 years and older)

Strength Selection

2 mg gum: Recommended for smokers who have their first cigarette more than 30 minutes after waking up. This indicates lower to moderate nicotine dependence.

4 mg gum: Recommended for smokers who have their first cigarette within 30 minutes of waking up. This indicates higher nicotine dependence and is also recommended for smokers who smoke 20 or more cigarettes per day.

Recommended Dosing Schedule for Nicorama Mint
Phase Duration Pieces Per Day Notes
Phase 1: Initial Treatment Weeks 1–6 8–12 pieces Use 1 piece every 1–2 hours; chew each piece for ~30 minutes
Phase 2: Gradual Reduction Weeks 7–9 4–8 pieces Reduce by 1 piece every 1–2 days; extend time between pieces
Phase 3: Tapering Off Weeks 10–12 1–4 pieces Use only for strong cravings; aim to stop by end of week 12

Maximum daily dose: Do not exceed 15 pieces of gum in any 24-hour period. Exceeding this dose increases the risk of nicotine-related adverse effects without providing additional benefit for smoking cessation.

Correct Chewing Technique: “Chew and Park”

Proper technique is critical for the effectiveness and tolerability of Nicorama Mint. Incorrect use is one of the most common reasons for perceived NRT failure:

  1. Place one piece of gum in your mouth and chew it slowly and deliberately – about one chew every 2–3 seconds. This is significantly slower than normal gum chewing.
  2. When you notice a tingling or peppery taste (usually after about 15–20 chews), stop chewing and park the gum between your cheek and gum. This allows nicotine to be absorbed through the oral mucosa.
  3. Leave the gum parked for about 1 minute until the taste fades, then resume slow chewing until the tingling returns again.
  4. Repeat this chew-and-park cycle for approximately 30 minutes. After this time, most of the available nicotine has been released and absorbed.
  5. Dispose of the used gum by wrapping it in paper or the foil wrapper and placing it in a waste bin. Do not swallow the gum.

Children and Adolescents

Nicorama Mint is not recommended for children under the age of 12. Adolescents aged 12–17 who are nicotine-dependent smokers should only use NRT under the supervision and guidance of a healthcare provider. The dosing principles are generally the same as for adults, but the treatment course may be shorter. Behavioral support and counseling are particularly important for this age group.

Elderly Patients

No specific dose adjustment is required for elderly patients. However, elderly individuals may be more susceptible to the cardiovascular effects of nicotine and may have age-related changes in hepatic and renal function that could affect nicotine metabolism. As with all patients, the benefits of smoking cessation with NRT far outweigh the risks of continued smoking, but closer clinical monitoring may be warranted in elderly patients with significant comorbidities.

Missed Dose

Because Nicorama Mint is used on an as-needed basis in response to cravings rather than on a fixed dosing schedule, the concept of a “missed dose” is not strictly applicable. However, if you find that you are consistently not using enough gum during the day and are experiencing breakthrough cravings or withdrawal symptoms, you should consider using gum on a more regular schedule (for example, one piece every 1–2 hours during waking hours) rather than waiting for cravings to become intense.

Overdose

The minimum lethal dose of nicotine in adults has traditionally been cited as approximately 40–60 mg, although more recent evidence suggests that the actual lethal dose may be substantially higher (approximately 500–1000 mg for an adult). Nevertheless, any suspected overdose should be treated as a medical emergency. In adults, the risk of acute toxicity from nicotine gum alone is relatively low because of the slow absorption and the fact that nausea (an early symptom of excessive nicotine intake) usually limits further use. However, children are at particular risk because their lower body weight means that even small amounts of nicotine can produce toxic effects.

What Are the Side Effects of Nicorama Mint?

Quick Answer: The most common side effects of Nicorama Mint include mouth and throat irritation, hiccups, jaw ache from chewing, nausea, and headache. Most side effects are mild, related to the chewing action or swallowed nicotine, and tend to decrease with proper technique and continued use. Serious adverse effects are rare.

Like all medicines, Nicorama Mint can cause side effects, although not everybody gets them. Many of the common side effects of nicotine gum are directly related to the local action of nicotine on the oral mucosa and the gastrointestinal effects of swallowed nicotine. Proper chewing technique (the “chew and park” method described in the dosage section) significantly reduces the incidence and severity of many of these side effects by minimizing the amount of nicotine that is swallowed rather than absorbed through the mouth.

It is also important to distinguish between side effects of the medication and symptoms of nicotine withdrawal, which may include irritability, frustration, anger, anxiety, difficulty concentrating, restlessness, depressed mood, insomnia, increased appetite, and weight gain. These withdrawal symptoms typically peak within the first few days to weeks of smoking cessation and gradually improve over time.

Very Common

May affect more than 1 in 10 people

  • Mouth and throat irritation or soreness
  • Hiccups
  • Jaw muscle ache or fatigue from chewing
  • Nausea (especially if gum is chewed too quickly)
  • Headache

Common

May affect up to 1 in 10 people

  • Dizziness or lightheadedness
  • Heartburn or indigestion (dyspepsia)
  • Excessive salivation
  • Taste disturbance or unpleasant taste
  • Flatulence (gas)
  • Abdominal discomfort
  • Insomnia (particularly with evening or nighttime use)

Uncommon

May affect up to 1 in 100 people

  • Palpitations or increased heart rate (tachycardia)
  • Skin rash or urticaria (hives)
  • Oral mucosal ulceration (mouth sores)
  • Flushing
  • Increased blood pressure
  • Difficulty swallowing (dysphagia)

Rare

May affect up to 1 in 1,000 people

  • Allergic reactions (angioedema, anaphylaxis)
  • Cardiac arrhythmias
  • Reversible atrial fibrillation

Mouth and throat irritation is the most frequently reported side effect and is caused by the local action of nicotine on the oral mucosa. This effect typically diminishes with continued use as the mucosal tissues adapt. Using the “chew and park” technique correctly – rather than chewing the gum continuously like regular gum – significantly reduces the severity of oral irritation. The mint flavoring in Nicorama Mint may also help soothe the throat, though some individuals may find mint itself mildly irritating.

Gastrointestinal side effects, particularly nausea, heartburn, and hiccups, are primarily caused by nicotine that is swallowed with saliva during chewing. When nicotine reaches the stomach, it stimulates gastric acid secretion and can cause local irritation of the gastric and esophageal mucosa. These effects are dose-related and are substantially reduced by proper chewing technique, which maximizes oromucosal absorption and minimizes the swallowing of nicotine-containing saliva.

Jaw ache and fatigue are mechanical side effects related to the repetitive chewing motion, particularly during the initial days of use. The gum base in Nicorama Mint is firmer than regular chewing gum to facilitate the controlled release of nicotine from the polacrilex resin. Most users find that jaw discomfort improves within the first week as the jaw muscles adapt to the chewing action. If jaw pain is severe or persistent, consider reducing the number of pieces used per day or switching to a different NRT formulation.

Dental considerations are also relevant with long-term nicotine gum use. Nicotine gum can adhere to dental restorations (fillings, crowns, bridges, and dentures) and may potentially damage them. Patients with extensive dental work should discuss this with their dentist. Additionally, the sugar-free sweeteners used in nicotine gum, while not causing dental caries, may have a mild laxative effect in some individuals if consumed in large quantities.

When to Seek Medical Attention

Contact your doctor or seek medical advice if you experience persistent chest pain, irregular heartbeat, severe dizziness, difficulty breathing, severe skin rash, or swelling of the face, lips, tongue, or throat. While these reactions are rare, they may indicate a serious allergic reaction or cardiovascular event that requires immediate medical evaluation.

How Should You Store Nicorama Mint?

Quick Answer: Store Nicorama Mint at room temperature below 25 °C (77 °F) in its original packaging to protect from moisture. Keep out of reach of children. Do not use after the expiration date printed on the packaging.

Proper storage of Nicorama Mint is important both for maintaining the quality and efficacy of the medication and for ensuring safety, particularly in households with children. Nicotine is a potent substance that retains its pharmacological activity even in used pieces of gum, making safe storage and disposal essential.

Follow these storage guidelines:

  • Temperature: Store at room temperature, below 25 °C (77 °F). Do not refrigerate or freeze, as temperature extremes can affect the texture and nicotine release properties of the gum.
  • Moisture protection: Keep the gum in its original blister packaging until ready for use. The blister pack protects individual pieces from moisture, which can alter the gum’s consistency and nicotine delivery characteristics.
  • Light protection: While not particularly light-sensitive, it is good practice to store the gum away from direct sunlight and heat sources.
  • Child safety: Store all nicotine gum – both unused and used pieces – out of the reach and sight of children. Nicotine poisoning in children can occur from chewing or swallowing used gum. Consider storing the gum in a high, locked cabinet.
  • Expiration date: Do not use Nicorama Mint after the expiration date printed on the packaging. The expiration date refers to the last day of the stated month. Expired gum may not deliver the correct dose of nicotine and should be disposed of properly.
  • Disposal of used gum: Wrap used pieces of gum in paper, foil, or the original blister wrapper and dispose of them in a waste bin. Used gum still contains residual nicotine and should never be left where children or pets can access it. Do not flush nicotine gum down the toilet.

When traveling, carry Nicorama Mint in your hand luggage to keep it accessible and to avoid exposure to extreme temperatures that may occur in checked luggage compartments. The gum is safe to carry through airport security screening. If traveling to destinations with high ambient temperatures, consider keeping the gum in an insulated bag to prevent the gum base from softening.

What Does Nicorama Mint Contain?

Quick Answer: Each piece of Nicorama Mint contains either 2 mg or 4 mg of nicotine bound to a polacrilex (ion exchange) resin in a sugar-free gum base with mint flavoring, sweeteners, and other excipients that control nicotine release and improve taste.

Understanding the composition of Nicorama Mint can help patients identify potential allergens or intolerances and understand how the medication works. The formulation is designed to provide controlled, gradual nicotine release during chewing while maintaining a pleasant mint taste.

Active Ingredient

The active substance is nicotine, present in the form of nicotine polacrilex (also known as nicotine resinate or nicotine bound to a polacrilin cation-exchange resin). Each piece of Nicorama Mint contains either 2 mg or 4 mg of nicotine. The polacrilex resin serves as the delivery vehicle for the nicotine, binding it in an ion-exchange matrix that releases nicotine gradually as the pH of the surrounding saliva changes during chewing. This controlled-release mechanism prevents the rapid delivery of nicotine that occurs with smoking and helps reduce the potential for abuse.

Inactive Ingredients (Excipients)

Nicorama Mint Composition: Active and Inactive Ingredients
Ingredient Role Notes
Nicotine polacrilex Active substance 2 mg or 4 mg per piece
Gum base Carrier matrix Provides structure for controlled nicotine release
Xylitol Sweetener Sugar-free; does not promote dental caries
Mint flavoring Flavoring agent Improves taste and palatability
Sodium carbonate pH adjuster / buffer Maintains alkaline pH for optimal nicotine release and absorption
Sodium bicarbonate pH adjuster / buffer Works with sodium carbonate to maintain oral pH
Acesulfame potassium Sweetener Intense sweetener; sugar-free

Allergen Information

Nicorama Mint is sugar-free and gluten-free. It does not contain lactose. However, patients with known sensitivities to any of the listed excipients – including mint flavoring compounds – should discuss alternatives with their healthcare provider. The gum base may contain butylated hydroxytoluene (BHT), which can rarely cause contact sensitivity in susceptible individuals.

Appearance and Pack Sizes

Nicorama Mint is supplied as individually sealed pieces of off-white to light beige medicated chewing gum with a characteristic mint scent. It is available in blister packs, typically containing 24, 48, 96, or 105 pieces. Not all pack sizes may be available in every country or market.

Frequently Asked Questions About Nicorama Mint

Nicorama Mint is a nicotine replacement therapy (NRT) medicated chewing gum used to help people quit smoking. It delivers a controlled dose of nicotine through the lining of the mouth, reducing the withdrawal symptoms and cravings that occur when a person stops smoking. It is intended for use by adult smokers as part of a comprehensive smoking cessation program, ideally combined with behavioral support and counseling for the best chance of success.

The choice of strength depends on your level of nicotine dependence. The simplest way to assess this is by how soon after waking you smoke your first cigarette. If you smoke your first cigarette more than 30 minutes after waking, the 2 mg strength is usually sufficient. If you smoke within 30 minutes of waking – indicating higher nicotine dependence – the 4 mg strength is recommended. Smokers who consume 20 or more cigarettes per day should also consider the 4 mg strength. Your healthcare provider or pharmacist can help determine the most appropriate strength for your needs.

Yes, combination NRT – using a nicotine patch for baseline nicotine delivery together with nicotine gum or lozenges for breakthrough cravings – is a well-established approach that has been shown in clinical trials to be more effective than using a single NRT product alone. This combination is recommended in several international treatment guidelines, particularly for heavily dependent smokers. However, combination therapy should ideally be initiated under the guidance of a healthcare provider to ensure appropriate dosing and to monitor for signs of excessive nicotine intake.

No, you should not chew Nicorama Mint like regular gum. It must be used with the “chew and park” technique for proper nicotine absorption: chew slowly until a tingling or peppery taste appears, then park the gum between your cheek and gum for about one minute to allow nicotine absorption through the oral mucosa. Repeat this cycle for about 30 minutes. Chewing too fast or continuously causes too much nicotine to be swallowed, which reduces effectiveness and increases the risk of gastrointestinal side effects such as nausea, hiccups, and heartburn.

A typical treatment course lasts 8 to 12 weeks, with gradual reduction in the number of pieces used per day. During weeks 1–6, use one piece every 1–2 hours. During weeks 7–9, reduce to one piece every 2–4 hours. During weeks 10–12, use only for strong cravings and aim to stop by the end of week 12. Most guidelines recommend not exceeding 6 months of continuous use, though some patients may need longer to prevent relapse. Prolonged NRT use, while not ideal, is considered substantially safer than returning to smoking.

While nicotine does have cardiovascular effects (increasing heart rate and blood pressure), extensive evidence shows that the cardiovascular risks of NRT are substantially lower than the risks of continued smoking. Major medical guidelines, including those from the American Heart Association and the European Society of Cardiology, support the use of NRT in patients with stable cardiovascular disease. However, patients with recent (within 4 weeks) heart attack, unstable angina, severe arrhythmias, or recent stroke should only use NRT under close medical supervision. Always discuss your cardiovascular history with your doctor before starting NRT.

References

  1. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018;5(5):CD000146. doi:10.1002/14651858.CD000146.pub5.
  2. Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019;4(4):CD013308. doi:10.1002/14651858.CD013308.
  3. World Health Organization (WHO). WHO Report on the Global Tobacco Epidemic, 2023. Available at: WHO Global Tobacco Report.
  4. National Institute for Health and Care Excellence (NICE). Tobacco: preventing uptake, promoting quitting and treating dependence. NICE Guideline NG209. 2023. Available at: NICE NG209.
  5. U.S. Department of Health and Human Services. Treating Tobacco Use and Dependence: 2008 Update – Clinical Practice Guideline (updated 2020). Available at: AHRQ Tobacco Guidelines.
  6. Benowitz NL. Nicotine Addiction. N Engl J Med. 2010;362(24):2295–2303. doi:10.1056/NEJMra0809890.
  7. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146.
  8. British National Formulary (BNF). Nicotine. National Institute for Health and Care Excellence (NICE). 2025.
  9. European Medicines Agency (EMA). Nicotine replacement therapy – Article 31 referral assessment report. 2020.
  10. Mayer B. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Arch Toxicol. 2014;88(1):5–7. doi:10.1007/s00204-013-1127-0.

About Our Medical Team

All content on iMedic is created and reviewed by qualified medical professionals following international evidence-based guidelines. Our editorial process ensures accuracy, currency, and clinical relevance.

Medical Content Team

Specialists in addiction medicine, clinical pharmacology, and public health with extensive experience in smoking cessation interventions and nicotine replacement therapy.

Medical Review Board

Independent panel of board-certified physicians who verify all medical claims against current evidence and international guidelines (WHO, NICE, Cochrane, EMA).

Editorial Standards

All content follows the GRADE evidence framework and is based on Level 1A evidence from systematic reviews and randomized controlled trials where available.

Independence

iMedic receives no pharmaceutical company funding or sponsorship. All content is editorially independent, ensuring unbiased medical information for patients and caregivers.